Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiency Diseases (PID)”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Large-scale testing (Phase 3)Study completedNCT02810444
What this trial is testing

Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID

Who this might be right for
Primary Immunodeficiency Disease
Biotest 81
Not applicableStudy completedNCT03716700
What this trial is testing

Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 126
Not applicableLooking for participantsNCT02735824
What this trial is testing

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

Who this might be right for
Immunologic Deficiency SyndromesPrimary Immune Deficiency (PID)
University Children's Hospital, Zurich 500
Large-scale testing (Phase 3)Study completedNCT00157079
What this trial is testing

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome
Baxalta now part of Shire 61
Post-approval studies (Phase 4)Study completedNCT03033745
What this trial is testing

Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency
CSL Behring 49
Large-scale testing (Phase 3)Study completedNCT04346108
What this trial is testing

Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 17
Not applicableStudy completedNCT01287689
What this trial is testing

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study

Who this might be right for
Primary Immunodeficiency (PID)Secondary Immunodeficiency (SID)Neurological Autoimmune Disease
Technische Universität Dresden 685
Large-scale testing (Phase 3)Study completedNCT01218438
What this trial is testing

Phase 2/3 Study of IGSC, 20% in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 86
Large-scale testing (Phase 3)Study completedNCT01175213
What this trial is testing

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 66
Large-scale testing (Phase 3)Looking for participantsNCT06954441
What this trial is testing

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency

Who this might be right for
ImmunodeficienciesPrimary Immunodeficiencies (PID)Agammaglobulinemia
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. 50
Testing effectiveness (Phase 2)Study completedNCT03330795
What this trial is testing

Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant

Who this might be right for
Primary ImmunodeficiencyPID
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)Study completedNCT00782106
What this trial is testing

Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV Subcutaneously

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 11
Post-approval studies (Phase 4)UnknownNCT02490956
What this trial is testing

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Who this might be right for
Primary Immunodeficiency
Chulalongkorn University 40
Not applicableStudy completedNCT01859754
What this trial is testing

Octagam 5% Versus Comparator Post Marketing Trial

Who this might be right for
Primary Immune Deficiency Disorder
Octapharma 623
Large-scale testing (Phase 3)Study completedNCT01485796
What this trial is testing

Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 54
Not applicableUnknownNCT05986734
What this trial is testing

Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Post-approval studies (Phase 4)Study completedNCT02180763
What this trial is testing

Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Who this might be right for
Primary Immunodeficiency (PID)
Octapharma 31
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Next Page